BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24604817)

  • 1. Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals.
    Fernandes SM; Pires AR; Ferreira C; Foxall RB; Rino J; Santos C; Correia L; Poças J; Veiga-Fernandes H; Sousa AE
    J Infect Dis; 2014 Aug; 210(4):630-40. PubMed ID: 24604817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis.
    Kim CJ; Nazli A; Rojas OL; Chege D; Alidina Z; Huibner S; Mujib S; Benko E; Kovacs C; Shin LY; Grin A; Kandel G; Loutfy M; Ostrowski M; Gommerman JL; Kaushic C; Kaul R
    Mucosal Immunol; 2012 Nov; 5(6):670-80. PubMed ID: 22854709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17 cells, HIV and the gut mucosal barrier.
    Dandekar S; George MD; Bäumler AJ
    Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication.
    Fernandes SM; Pires AR; Matoso P; Ferreira C; Nunes-Cabaço H; Correia L; Valadas E; Poças J; Pacheco P; Veiga-Fernandes H; Foxall RB; Sousa AE
    Mucosal Immunol; 2018 Jan; 11(1):236-248. PubMed ID: 28513595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy.
    Krämer B; Goeser F; Lutz P; Glässner A; Boesecke C; Schwarze-Zander C; Kaczmarek D; Nischalke HD; Branchi V; Manekeller S; Hüneburg R; van Bremen T; Weismüller T; Strassburg CP; Rockstroh JK; Spengler U; Nattermann J
    PLoS Pathog; 2017 May; 13(5):e1006373. PubMed ID: 28505204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy.
    Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T
    J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
    Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils in antiretroviral therapy-controlled HIV demonstrate hyperactivation associated with a specific IL-17/IL-22 environment.
    Campillo-Gimenez L; Casulli S; Dudoit Y; Seang S; Carcelain G; Lambert-Niclot S; Appay V; Autran B; Tubiana R; Elbim C
    J Allergy Clin Immunol; 2014 Nov; 134(5):1142-52.e5. PubMed ID: 25042982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors.
    Sankaran S; Guadalupe M; Reay E; George MD; Flamm J; Prindiville T; Dandekar S
    Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9860-5. PubMed ID: 15980151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study.
    Iannello A; Boulassel MR; Samarani S; Debbeche O; Tremblay C; Toma E; Routy JP; Ahmad A
    J Immunol; 2010 Jan; 184(1):114-26. PubMed ID: 19949086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
    Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
    Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial.
    Chege D; Kovacs C; la Porte C; Ostrowski M; Raboud J; Su D; Kandel G; Brunetta J; Kim CJ; Sheth PM; Kaul R; Loutfy MR
    AIDS; 2012 Jan; 26(2):167-74. PubMed ID: 22089379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors.
    Ciccone EJ; Greenwald JH; Lee PI; Biancotto A; Read SW; Yao MA; Hodge JN; Thompson WL; Kovacs SB; Chairez CL; Migueles SA; Kovacs JA; Margolis LB; Sereti I
    J Virol; 2011 Jun; 85(12):5880-8. PubMed ID: 21471231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Th17 cells expressing β7 intestinal homing receptor in recent and chronic HIV infections.
    Márquez-Coello M; Montes-de-Oca Arjona M; Fernández-Gutiérrez Del Álamo C; Ruiz-Sánchez C; Girón-González JA
    Clin Exp Immunol; 2018 Dec; 194(3):350-360. PubMed ID: 30101536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of distribution and function of plasmacytoid dendritic cells in peripheral blood and gut mucosa of HIV infected patients.
    Lehmann C; Jung N; Förster K; Koch N; Leifeld L; Fischer J; Mauss S; Drebber U; Steffen HM; Romerio F; Fätkenheuer G; Hartmann P
    J Infect Dis; 2014 Mar; 209(6):940-9. PubMed ID: 24259523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.